Adcock Ingram: Next steps for pharmaceutical group as Bidvest takes command

After a protracted takeover battle, Bidvest is set to take control of South African pharmaceutical group Adcock Ingram (to see its share price and financials, visit the Biznews.com data bank: JSE:AIP). In this interview with Biznews.com editor Alec Hogg on CNBC Power lunch, investment expert Mark Ingham of Ingham Analytics explores what’s next for the company. … Read more

Report back from Adcock General Meeting: CFR struggles to sell bid as PIC, Bidvest say it’s waste of time

Let it never be said that mergers and acquisitions are boring, not when there are deals like Chilean-based CFR Pharmaceuticals’ dramatic and controversial bid for South African pharmaceutical company Adcock Ingram going down. As you may know, the mooted deal has been floundering because the Public Investment Corporation (PIC), which holds 18.9% of Adcock’s stock, … Read more

Battle for Adcock UPDATED: CFR statement hints at all-cash option after “kingmaker” PIC rejects revised offer

Ever since family-owned Chilean group CFR expressed interest in acquiring underperforming SA group Adcock Ingram, some leading shareholders urged it to put a cash-only offer on the table.  With hindsight, had the Weinstein family done so a month back, they would now be preparing to taking their Adcock “bride” home. Instead, over the weekend the … Read more